Marianne Mertens
InvestorPartner at Apollo Health Ventures
Germany
Writes $100K – $5M checks · typically $1.5M
About
Marianne Mertens is a Partner at Apollo Health Ventures, which she joined in 2021, focusing on the life sciences sector. She has over a decade of experience across venture investing, strategy consulting, and research, having previously worked as a Principal at Wellington Partners and an Investment Manager at High-Tech Gründerfonds (HTGF), and earlier as a management consultant for pharmaceutical and medical technology companies. She holds Bachelor's and Master's degrees in Biotechnology from RWTH Aachen University and The Scripps Research Institute, and conducted PhD research on molecular imaging of cardiac regenerative medicines.
Invests in
BiotechHealthtech
Investments
Led
Cardior TherapeuticsConfo TherapeuticsImCheck TherapeuticsTherini Bio
Board seats
Auron TherapeuticsBooster TherapeuticsCleara TherapeuticsHAYA Therapeutics
Per the firm's website.
Colleagues at Apollo Health Ventures
Network1
Investors connected to Marianne in public investor directories — a warm-intro map.